Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel DPP II inhibitor characterized at ActivX

Jan. 18, 2007

Novel treatments for cancer covered in recent patent literature

Jan. 18, 2007

Cleveland BioLabs enters research partnership with Roswell Park Cancer Institute

Jan. 17, 2007

Third interim analysis due in pivotal breast cancer study of tesmilifene

Jan. 17, 2007

Promising preclinical results with raloxifene-derived selective estrogen receptor modulator

Jan. 16, 2007

Metastatic pancreatic cancer patients show clinical responses to talabostat therapy

Jan. 16, 2007

Progress in phase I study of anticancer compound ECO-4601

Jan. 16, 2007

Poniard and Scripps Research Institute to discover FAK inhibitors

Jan. 16, 2007

Voraxaze progress updated

Jan. 15, 2007

Endoscopic ultrasound administration of TNFerade cleared for use in PACT trial

Jan. 15, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....